Overview

Psilocybin in Adults With and Without Autism Spectrum Disorder

Status:
Recruiting

Trial end date:
2024-12-01

Target enrollment:

Participant gender:

Summary

This study will test the hypothesis that brain systems are differentially regulated by serotonin in individuals with and without Autism Spectrum Disorder.

Phase:

N/A

Details

Lead Sponsor:

King's College London

Collaborator:

University of Cambridge

Treatments:

Psilocybin